£28mil boost for UK neuromuscular research

Published Date
12/07/2017
Author
Jenny Sharpe
Category
Research

We are delighted to hear that over £28 million has been awarded to University College London (UCL) to boost research into neuromuscular conditions and other neurological conditions. This will support the improvement of UCL’s research facilities and create an environment in which basic research can be translated into potential therapies.

Professor Michael Hanna (pictured), Director of the UCL Institute of Neurology and Chair of Muscular Dystrophy UK, had a key role in securing this award from the UK Research Partnership Investment Fund (UKRPIF).

Part of the UKRPIF funding was attained with the help of Muscular Dystrophy UK. We underlined our £4 million financial commitment over the next five years, which led to an extra £2 million funding from the UKRPIF.

The UKRPIF award will bring together the UCL Institute of Neurology at Queens Square and the new UK Dementia Research Institute at UCL. This will help to transform neuromuscular research in the UK by connecting researchers across different disciplines and attracting leading experts from around the world.

Professor Michael Hanna, Director of the UCL Institute of Neurology and Chair of Muscular Dystrophy UK, said:

This major award significantly advances progress towards our vision to create the world’s leading centre for translational neuroscience which will enable us to find treatments, train the next generation and work in close partnerships with industry, funders and patients.

Robert Meadowcroft, Chief Executive Officer of Muscular Dystrophy UK, said:

This is great news for people living with neuromuscular conditions, and the neuromuscular field in the UK, as well as for neurological disease research as a whole.

We are pleased to be a key partner in the new development at Queen Square and are delighted to work with Professor Mike Hanna and other expert clinicians and researchers. This funding commitment means we can now work in partnership towards developing an integrated neuromuscular hub for translational medicine and clinical trials in London.

Further information

For more information, read UCL’s press release

Read more about Prof Mike Hanna and our Trustees

Find out about research that MDUK is funding

Keep in touch
X
- Enter Your Location -
- or -